We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Panobinostat (LBH589) in Patients With Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065467
Recruitment Status : Completed
First Posted : February 9, 2010
Last Update Posted : March 28, 2017
Brigham and Women's Hospital
Information provided by (Responsible Party):
F. Stephen Hodi, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2013
  Study Completion Date : March 13, 2017